| Recurrent rearrangements in PRKACA and PRKACB in intraductal oncocytic papillary neoplasms of the pancreas and bile duct AD Singhi, LD Wood, E Parks, MS Torbenson, M Felsenstein, RH Hruban, ... Gastroenterology 158 (3), 573-582. e2, 2020 | 126 | 2020 |
| Renal cell carcinoma with chromosome 6p amplification including the TFEB gene: a novel mechanism of tumor pathogenesis? SR Williamson, DJ Grignon, L Cheng, L Favazza, DD Gondim, ... The American journal of surgical pathology 41 (3), 287-298, 2017 | 66 | 2017 |
| Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database L Favazza, DA Chitale, R Barod, CG Rogers, S Kalyana-Sundaram, ... Modern Pathology 30 (11), 1603-1612, 2017 | 32 | 2017 |
| KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy LA Favazza, CM Parseghian, C Kaya, MN Nikiforova, S Roy, AI Wald, ... Modern pathology 33 (9), 1832-1843, 2020 | 21 | 2020 |
| Gene fusion characterisation of rare aggressive prostate cancer variants—adenosquamous carcinoma, pleomorphic giant‐cell carcinoma, and sarcomatoid carcinoma: an analysis of … M Alhamar, I Tudor Vladislav, SC Smith, Y Gao, L Cheng, LA Favazza, ... Histopathology 77 (6), 890-899, 2020 | 18 | 2020 |
| Chromosome 6p amplification including the TFEB gene: a novel mechanism of renal cell carcinoma pathogenesis? SR Williamson, DJ Grignon, L Favazza, NS Gupta, DA Chitale, ... LABORATORY INVESTIGATION 96, 270A-271A, 2016 | 3 | 2016 |
| Clinical outcomes of patients with tumoral displacement into fallopian tubes in patients treated by robotically assisted hysterectomy for newly diagnosed endometrial cancer L Favazza, R Soslow, M Leitao, D DeLair LABORATORY INVESTIGATION 98, 419-420, 2018 | 1 | 2018 |
| Reproducibility of Oncotype DX recurrence score using Magee equations in breast cancers L Favazza, D Schultz, D Chitale LABORATORY INVESTIGATION 95, 44A-44A, 2015 | 1 | 2015 |
| USP6 Fusion Partners Identified by Next Generation Sequencing in Nodular Fasciitis and Cellular Fibroma of Tendon Sheath: An Institutional Experience S Rodgers, H Mehrotra, L Favazza, K Perry | | 2022 |
| Clinicopathological Characteristics and Response to Targeted Therapy in Patients with ALKrearranged Non-small-cell Lung Carcinoma harboring TP53 Mutations H Mehrotra, S Rodgers, L Favazza, D Chitale | | 2022 |
| Rate of Diagnosis Upgrade to Carcinoma in Patients with Core Biopsy Diagnosis of Intraductal Papilloma: A Single Institution Experience A Vijayanarayanan, K Ginnebaugh, L Favazza, S Husain, N Gupta, ... LABORATORY INVESTIGATION 101 (SUPPL 1), 157-158, 2021 | | 2021 |
| Comparison of DNA and RNA Based Sequencing for Detecting MET exon 14 Skipping Mutations and Their Morphologic Correlate in Patients with Non-Small Cell Lung Cancer H Mehrotra, K Arora, L Favazza, D Chitale LABORATORY INVESTIGATION 101 (SUPPL 1), 1124-1126, 2021 | | 2021 |
| Resolution of a modified CDC definition for carbapenem resistant enterobacteriaceae (CRE) using a rapid multiplex, cartridge-based molecular assay for the confirmation of … H Mehrotra, L Favazza, B Kezlarian, R Fowler, N Hanson, RJ Tibbetts | | 2020 |
| Clinical Utility of Oncomine Next-Generation Sequencing Test for Calculation of Tumor Mutation Burden C Kaya, L Favazza, A Karunamurthy, S Roy, YE Nikiforov, MN Nikiforova, ... JOURNAL OF MOLECULAR DIAGNOSTICS 21 (6), 1194-1194, 2019 | | 2019 |
| KRAS Amplifications in Metastatic Colorectal Carcinoma (mCRC) are Frequently Detected in Younger Patients with a History of Inflammatory Bowel Disease and May Confer Resistance … L Favazza, L Santana-Santos, A Wald, S Roy, M Nikiforova, M Landau, ... LABORATORY INVESTIGATION 99, 2019 | | 2019 |
| Utilization of the three Magee equations to select patients for genomic testing H Ali, Z Abdel-Rahman, L Favazza, DA Chitale | | 2018 |
| Poor concordance between 21-gene expression assay recurrence score and all Magee equation recurrence scores in a consecutive cohort of patients treated for hormone receptor … Z Abdel-Rahman, HY Ali, L Favazza, DA Chitale | | 2017 |
| Assessment of the Immune Microenvironment in Estrogen Receptor Positive Invasive Breast Cancers and Its Correlation to Clinicopathologic Parameters L Favazza, B Kezlarian, J Arias-Stella, D Schultz, D Chitale American Journal of Clinical Pathology 146 (suppl_1), 27, 2016 | | 2016 |
| Does Tumor Infiltrating Lymphocyte (TIL) Count Influence Oncotype DxTM Recurrence Score and Magee Equation Scores? B Kezlarian, L Favazza, J Arias-Stella, D Schultz, DA Chitale LABORATORY INVESTIGATION 96, 49A-49A, 2016 | | 2016 |
| Programmed Cell Death Ligand 1 (PD-L1) Expression in Estrogen Receptor Positive (ER plus) Invasive Breast Cancers (BC): A Pilot Study of 148 Cases J Arias-Stella, B Kezlarian, L Favazza, D Schultz, DA Chitale LABORATORY INVESTIGATION 96, 29A-29A, 2016 | | 2016 |
